C-MER Eye Care Holdings Limited (HK:3309) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
C-MER Medical Group, a subsidiary of C-MER Eye Care Holdings Limited, has announced a $1 million investment in Health Hope Pharma as part of a Series A funding round. This investment will result in C-MER holding approximately 23% of Health Hope Pharma’s shares, a clinical-stage biotech company focused on developing oral anti-cancer drugs. This strategic move aligns with C-MER’s growth plans and expands its presence in the biotech sector.
For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.